Harries Lorna W, Hattersley Andrew T, Ellard Sian
Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, U.K.
Diabetes. 2004 Feb;53(2):500-4. doi: 10.2337/diabetes.53.2.500.
Mutations in the hepatocyte nuclear factor-1alpha (HNF-1a) gene cause maturity-onset diabetes of the young (MODY). Approximately 30% of these mutations generate mRNA transcripts harboring premature termination codons (PTCs). Degradation of such transcripts by the nonsense-mediated decay (NMD) pathway has been reported for many genes. To determine whether PTC mutant transcripts of the HNF-1alpha gene elicit NMD, we have developed a novel quantitative RT-PCR assay. We performed quantification of ectopically expressed mutant transcripts relative to normal transcripts in lymphoblastoid cell lines using a coding single nucleotide polymorphism (cSNP) as a marker. The nonsense mutations R171X, I414G415ATCG-->CCA, and P291fsinsC showed reduced mutant mRNA expression to 40% (P = 0.009), <0.01% (P </= 0.0001), and 6% (P = 0.001), respectively, of the normal allele. Transcript levels were restored using the translation inhibitor cycloheximide, indicating that the instability arises from NMD. The missense mutations G207D and R229P did not show NMD although R229P exhibited moderate RNA instability. This study provides the first evidence that HNF-1alpha PTC mutations may be subject to NMD. Mutations that result in significant reduction of protein levels due to NMD will not have dominant-negative activity in vivo. Haploinsufficiency is therefore likely to be the most important mutational mechanism of HNF-1alpha mutations causing MODY.
肝细胞核因子-1α(HNF-1α)基因的突变会导致青年发病的成年型糖尿病(MODY)。这些突变中约30%会产生含有提前终止密码子(PTC)的mRNA转录本。许多基因的此类转录本会通过无义介导的衰变(NMD)途径降解。为了确定HNF-1α基因的PTC突变转录本是否引发NMD,我们开发了一种新型定量逆转录聚合酶链反应(RT-PCR)检测方法。我们使用编码单核苷酸多态性(cSNP)作为标记,在淋巴母细胞系中对异位表达的突变转录本相对于正常转录本进行定量。无义突变R171X、I414G415ATCG→CCA和P291fsinsC的突变型mRNA表达分别降至正常等位基因的40%(P = 0.009)、<0.01%(P≤0.0001)和6%(P = 0.001)。使用翻译抑制剂环己酰亚胺可恢复转录水平,表明这种不稳定性源于NMD。错义突变G207D和R229P未显示NMD,尽管R229P表现出中等程度的RNA不稳定性。本研究首次证明HNF-1α的PTC突变可能会受到NMD的影响。由于NMD导致蛋白质水平显著降低的突变在体内不会具有显性负性活性。因此,单倍体不足可能是HNF-1α突变导致MODY的最重要突变机制。